Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported 5.8 thousand tonnes of antisera and other blood fractions totaling 25.7 billion USD, 8% over the previous year. Its primary trading partner was Germany, where it supplied 15.6% of its total antisera and other blood fractions exports in value terms, accounting for 24.2% of Germany's total imports.

From 2007 to 2014, Switzerland was a net exporter of antisera and other blood fractions. In this period, exports consistently exceeded imports in value terms. However, in physical terms, imports exceeded exports.

Germany and the U.S. were among the other main global suppliers of antisera and other blood fractions in 2014. However, the fastest growing exporters from 2007 to 2014 were the United Kingdom (+43.4% per year) and Spain (+27.5% per year). By nature of this, the United Kingdom significantly strengthened its position in the global export structure.

In 2014, Switzerland's top 5 trading partners were Germany, the U.S., Italy, Belgium and France, with a combined 50.4% share of Switzerland's antisera and other blood fractions exports. The share of the U.S. rose by +5.5 percentage points, while the share of Italy illustrated negative dynamics (-5.5 percentage points).